Table 5.
Univariate logistic regression analysis on basic imaging factors associated with therapeutic effect.
| Variants | Remission | Progression | ||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| SUVmax | ||||
| <36.37 | 1 | 1 | ||
| ≥36.37 | 1.91 (0.53,7.31) | 0.33 | 0.33 (0.06,1.43) | 0.15 |
| SUVpeak | ||||
| <26.38 | 1 | 1 | ||
| ≥26.38 | 3 (0.81,12.24) | 0.11 | 0.33 (0.06,1.43) | 0.15 |
| wbPSMA-TV | ||||
| <280.64 | 1 | 1 | ||
| ≥280.64 | 1.24 (0.34,4.56) | 0.74 | 0.58 (0.13,2.46) | 0.47 |
| wbTL-PSMA | ||||
| <2460.10 | 1 | 1 | ||
| ≥2460.10 | 1.24 (0.34,4.56) | 0.74 | 1 (0.23,4.30) | 1.00 |
| T/BPET/CT | ||||
| <8.06 | 1 | 1 | ||
| ≥8.06 | 3 (0.81,12.24) | 0.11 | 0.33 (0.06,1.43) | 0.15 |
| T/BSPCET/CT | ||||
| <3.20 | 1 | 1 | ||
| ≥3.20 | 1.24 (0.34,4.56) | 0.94 | 0.58 (0.13,2.46) | 0.47 |
| Number of lesions | ||||
| <40 | 1 | 1 | ||
| ≥40 | 1.24 (0.34,4.56) | 0.74 | 0.58 (0.13,2.46) | 0.47 |
| Visceral metastasis | ||||
| Yes | 1 | 1 | ||
| No | 0.76 (0.14,4.41) | 0.75 | 2.79 (0.46,15.82) | 0.24 |
T/B, the target/background ratio.